Global Head of Precision Medicine and Diagnostics at Janssen Pharmaceutical (jnj.com/innovation/preventing-lung-cancer-from-happening-in-the-first-place) sits down with Kevin Keegan, GM Oncology at Illumina to discuss precision medicine. They explore what it takes in terms of partnerships, clinical utility data and targeted therapies coming together with actionable diagnostic data to serve physicians, patients broadly and consistently. Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: facebook.com/illuminainc LinkedIn: linkedin.com/company/illu... Instagram: instagram.com/illuminainc Twitter: twitter.com/illumina #Genomics #GenomeEra #Illumina #BetterHumanHealth #Janssen #PrecisionMedicine, #WGS #Partnerships #ActionableDiagonsticData #ClinicalUtility #IGF #IlluminaGenomicsForum #LightboxConversations